Ranibizumab and bevacizumab show equivalent effects on visual acuity in patients with neovascular AMD

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2011年 / 46卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [1] Differences of frequency in administration of ranibizumab and bevacizumab in patients with neovascular AMD
    Scholler, Andreas
    Richter-Mueksch, Sibylla
    Weingessel, Birgit
    Vecsei-Marlovits, Pia-Veronika
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (11-12) : 355 - 359
  • [2] Visual Acuity Outcomes in Neovascular AMD Patients Receiving Series of Three Ranibizumab Injections on Indication
    Vora, A. V.
    Ranchod, T. M.
    Walsh, M. K.
    Shobe, B.
    Harinandan, A.
    Alfares, S.
    Drenser, K. A.
    Hassan, T. S.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [3] Aflibercept (Eylea) Effect on Macula Thickness and Visual Acuity in Exudative AMD Patients Recalcitrant to Ranibizumab and Bevacizumab
    Hau, Vincent
    Samuel, Mike
    Davis, Michael
    Lin, Kristie
    Chang, Tom
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [4] Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
    Avery, Robert L.
    Castellarin, Alessandro A.
    Steinle, Nathan C.
    Dhoot, Dilsher S.
    Pieramici, Dante Joseph
    See, Robert
    Couvillion, Stephen
    Nasir, Ma'an A.
    Rabena, Melvin D.
    Le, Kha
    Maia, Mauricio
    Visich, Jennifer E.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (12) : 1636 - 1641
  • [5] Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD
    Waldstein, Sebastian M.
    Wright, Jonathan
    Warburton, James
    Margaron, Philippe
    Simader, Christian
    Schmidt-Erfurth, Ursula
    [J]. OPHTHALMOLOGY, 2016, 123 (01) : 60 - 69
  • [6] Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab
    Massamba, N.
    Dirani, A.
    Knoeri, J.
    Pasquier, B.
    Ingram, A.
    Soubrane, G.
    [J]. EYE, 2015, 29 (11) : 1453 - 1457
  • [7] Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab
    N Massamba
    A Dirani
    J Knoeri
    B Pasquier
    A Ingram
    G Soubrane
    [J]. Eye, 2015, 29 : 1453 - 1457
  • [8] Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
    Maria Waizel
    Margarita G. Todorova
    Michael Masyk
    Katharina Wolf
    Annekatrin Rickmann
    Khaled Helaiwa
    Björn R. Blanke
    Peter Szurman
    [J]. BMC Ophthalmology, 17
  • [9] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Feng, Xue-Feng
    Constable, Ian J.
    McAllister, Ian L.
    Isaacs, Timothy
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 85 - 88
  • [10] Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
    Waizel, Maria
    Todorova, Margarita G.
    Masyk, Michael
    Wolf, Katharina
    Rickmann, Annekatrin
    Helaiwa, Khaled
    Blanke, Bjoern R.
    Szurman, Peter
    [J]. BMC OPHTHALMOLOGY, 2017, 17
12345